New nerve block could slash opioid use after heart surgery

NCT ID NCT07259824

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a specific nerve block, called SPSIPB, can reduce pain and the need for strong painkillers after minimally invasive heart surgery. Fifty adults were split into two groups: one got the nerve block plus standard care, the other got standard care alone. Researchers measured total opioid use in the first 24 hours after surgery, along with pain scores and recovery speed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If effective, this nerve block could become a standard way to reduce pain and opioid use after minimally invasive heart surgery.
What could go wrong
This is a small, single-center study with only 50 participants. The nerve block may not provide significant benefit over standard care, and there are risks like bleeding or infection from the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART VALVULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.